ArticleLeukemia2019
The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials.
Tobias W Klausen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled itcites it